MP1-06 CLINICAL BENEFITS AND COSTS OF A 17-GENE ASSAY DESIGNED TO ASSESS DISEASE-PROGRESSION RISK AFTER POSITIVE PROSTATE CANCER BIOPSY.

Autor:	Dall'Era, Marc, Michalopoulos, Steven N., Denes, Béla S., Tighe, Jennifer, Hornberger, John
Předmět:	DISEASE progression PROSTATE cancer BIOPSY WATCHFUL waiting PROSTATECTOMY HEALTH risk assessment
Zdroj:	Journal of Urology; Apr2015 Supplement, Vol. 193, pe2-e3, 1p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu